Objective To analyze the correlation between trabecular bone score (TBS) and bone metabolic markers in patients with type 2 diabetic osteoporosis. Methods A retrospective analysis was conducted in 115 cases of type 2 diabetic osteoporosis. According to the TBS, the patients were divided into osteoporosis group (62 cases) and non osteoporosis group (53 cases). Bone mineral density (BMD), TBS, and bone metabolic markers were compared between the two groups. The correlation between bone metabolic markers and TBS in osteoporosis group was analyzed. Results There was no statistical difference in BMD of the total lumbar and lumbar (L1-L4) between the two groups (P>0.05). TBS was significantly higher in osteoporosis group than in non osteoporosis group, with statistically significant difference (P<0.05). BGP, β-CTX, and TRAP-5b in osteoporosis group were significantly higher than in non osteoporosis group, with the statistically significant difference (P<0.05). There was no statistical difference in the levels of NBAP, P1NP, and 25-(OH)VD between the two groups (P>0.05). Pearson correlation analysis showed that BGP, β-CTX, and TRAP-5b were negatively correlated with TBS in osteoporosis group (r=-0.213, -0.247, -0.235, P<0.05). Conclusion Bone metabolic markers and TBS are correlated in patients with type 2 diabetic osteoporosis. TBS combined with BGP, β-CTX, and TRAP-5b is considered useful in early diagnosis and therapeutic monitoring in patients with type 2 diabetic osteoporosis probably. |